Is TKBIF or RYLD a better dividend investment in 2026?

TKBIF currently yields 1.58% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between TKBIF and RYLD?

TKBIF has a forward dividend yield of 1.58% ($0.12/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 10.56 percentage points.

Home › Compare › TKBIF vs RYLD

TKBIF vs RYLD: Dividend Comparison 2026

TKBIF yields 1.58% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $22.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

TKBIF

● Live price

1.58%

Share price

$7.30

Annual div

$0.12

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.0K

Annual income

$174.62

Full TKBIF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — TKBIF vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TKBIF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TKBIF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TKBIF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TKBIF

Annual income on $10K today (after 15% tax)

$134.02/yr

After 10yr DRIP, annual income (after tax)

$148.43/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, RYLD beats the other by $2,050.82/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TKBIF + RYLD for your $10,000?

TKBIF: 50%RYLD: 50%

100% RYLD50/50100% TKBIF

Portfolio after 10yr

$33.2K

Annual income

$1,380.98/yr

Blended yield

4.15%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TKBIF buys

RYLD buys

No recent congressional trades found for TKBIF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTKBIFRYLD

Forward yield	1.58%	12.14% ✓
Annual dividend / share	$0.12	$1.81 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$22.0K	$44.5K ✓
Annual income after 10y	$174.62	$2,587.35 ✓
Total dividends collected	$1.7K	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: TKBIF vs RYLD ($10,000, DRIP)

Year	TKBIF Portfolio	TKBIF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$10,858	$157.67	$11,914	$1,213.65	$1.1K → RYLD
2	$11,778	$159.99	$14,099	$1,351.30	$2.3K → RYLD
3	$12,764	$162.20	$16,580	$1,494.55	$3.8K → RYLD
4	$13,822	$164.29	$19,384	$1,642.61	$5.6K → RYLD
5	$14,956	$166.26	$22,535	$1,794.70	$7.6K → RYLD
6	$16,171	$168.13	$26,063	$1,950.00	$9.9K → RYLD
7	$17,473	$169.90	$29,995	$2,107.69	$12.5K → RYLD
8	$18,868	$171.57	$34,361	$2,266.99	$15.5K → RYLD
9	$20,361	$173.14	$39,194	$2,427.12	$18.8K → RYLD
10	$21,961	$174.62	$44,525	$2,587.35	$22.6K → RYLD

TKBIF vs RYLD: Complete Analysis 2026

TKBIF — Stock

Takara Bio Inc., together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names. It also provides contract services for regenerative medicine products, such as manufacturing of viral vectors and gene-transduced cells, quality and safety testing, and cell banking; and contract services for gene analysis and testing, including sequencing, intestinal flora analysis, comprehensive analysis of cancer-associated genes, and cell line creation through genome editing. In addition, the company is involved in developing platform technology for biologics development in areas, such as gene therapy. The company was incorporated in 2002 and is based in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.

Full TKBIF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this TKBIF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TKBIF vs SCHD TKBIF vs JEPI TKBIF vs O TKBIF vs KO TKBIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.